Showing posts sorted by date for query BALTIMORE. Sort by relevance Show all posts
Showing posts sorted by date for query BALTIMORE. Sort by relevance Show all posts

Friday, June 05, 2026

Trump Moved to Eliminate Chemical Safety Board Before Deadly Spill Killed 11


New polling shows even 82 percent of Trump supporters want stronger federal protections from toxic pollution.

June 5, 2026

Community members hold photographs of loved ones during a vigil at R.A. Long Park following a fatal chemical storage tank failure on May 26, 2026, in Longview, Washington.Mathieu Lewis-Rolland / Getty Images


Truthout is an indispensable resource for activists, movement leaders and workers everywhere. Please make this work possible with a quick donation.

In photos taken from above, the collapsed tank at the Nippon Dynawave paper mill in Longview, Washington, looks like a crushed tin can. Capable of holding 900,000 gallons of chemicals, the massive tank was filled to 90 percent capacity when it ruptured on the morning of May 26.

Norman Barlow’s family says he worked as an electrical engineer at the Nippon mill for only three months before the collapsing tank released a wave of toxic fumes and liquid, killing Barlow and 10 other workers. The 58-year-old from Vancouver was already “trying to leave” the job due to “safety concerns” and “how the place was ran,” according to his daughter, Brooke Iverson.

“My dad was really just trying to get out of there as soon as he could,” Iverson said in an interview with KGW. Iverson said the families of the 11 victims deserve answers about how the nation’s latest chemical disaster could have been prevented.

However, the Trump administration has asked Congress to eliminate the only independent federal agency that investigates major chemical accidents while systemically rolling back environmental regulations, including rules designed to protect communities from toxic spills. New polling suggests a bipartisan majority of voters are increasingly worried about toxic chemicals and want stronger federal protection from air and water pollution, which can increase health care costs.

“Nippon’s time is coming,” Iverson said. “They’re on a clock now — a clock of answers, a clock of what happens now.”

The paper mill is a major employer in Longview, a community now in mourning. The tank contained a toxic byproduct known as “white liquor” that burns human skin on contact. The chemical killed more than 2,000 fish after spilling into local waterways and the Columbia River, but officials have said drinking water is safe. It took days for crews to clean up the toxic spill and remove the victims. State and federal investigations are ongoing, leaving neighbors and families to wait for answers.

The U.S. Chemical Safety and Hazard Investigation Board opened an investigation and dispatched a team to Longview on May 27, one day after the incident. Congress created the independent federal watchdog in 1990 to hold polluters accountable and recommend safety improvements after major industrial accidents, which are alarmingly common in the United States.

In addition to investigating seven other industrial accidents, the Chemical Safety Board is currently investigating a toxic gas leak on April 22 that killed two workers and injured 19 at a troubled refinery in West Virginia’s Kanawha Valley, an area with a long history of industrial fires, explosions, and chemical spills. The board is also examining an explosion at a Pennsylvania steel plant that killed two workers and injured more than a dozen in August 2025.

President Donald Trump’s proposed 2027 federal budget would eliminate the Chemical Safety Board.

However, President Donald Trump’s proposed 2027 federal budget would eliminate the Chemical Safety Board as part of an apparent effort to rid the federal government of civil servants who might resist the president’s ever-shifting political whims. Echoing lobbyists for polluting industries, the White House claims the safety board “duplicates” work done by the Environmental Protection Agency (EPA), producing “unprompted studies” and proposing “regulations” it has no authority to enforce.

Unlike the EPA, the Chemical Safety Board operates independently from the president’s cabinet and political appointees. With an annual budget of about $14 million, the board cannot enforce regulations, but its investigations into fires, spills, explosions, and other accidents result in recommendations for regulators and private companies to make chemical storage and processing safer for workers and surrounding communities.

Congress rejected the White House’s original proposal to shut down the U.S. Chemical Safety Board by October 2025, but House Republicans are now pushing a budget bill that would cut the watchdog’s funding by 40 percent.

Meanwhile, the Trump administration has also taken a sledgehammer to the EPA by firing staff, slashing budgets, and undermining independent scientists studying the effects of toxic pollution on public health. Under EPA Administrator Lee Zeldin, the agency is systematically weakening federal environmental protections, including rules finalized in 2024 that require industrial polluters to coordinate with local first responders and create risk-management plans for handling dangerous chemicals near residential areas. For example, the EPA is moving to scrap a rule that would have required industrial facilities to use safer (but potentially more expensive) chemicals and technology in some cases.

Ana Parras, executive director of Texas Environmental Justice Advocacy Services, called the EPA’s proposed changes “a direct assault on safety and a political gift to polluters,” in a statement on February 19. “For fenceline communities and facility workers, this rollback is a declaration that our lives are deemed acceptable sacrifices,” Parras added.

A nationwide poll of 2,025 registered voters released on June 3 suggests Trump’s deregulatory agenda is not meeting the expectations of voters after the president promised to deliver the “cleanest air and water on Earth” during his 2024 campaign.


By an 8 to 1 margin, voters across the political spectrum said the EPA should prioritize protecting public health from toxic pollution over reducing regulations — even if it means higher costs.

By an 8 to 1 margin, voters across the political spectrum said the EPA should prioritize protecting public health from toxic pollution over reducing regulations — even if it means higher costs. The cost of health care remains a top concern, and 81 percent said the rollback of EPA regulations is shifting the burden of pollution “onto families through medical bills and long-term health consequences.”

“They aren’t buying the idea that rolling back protections makes life more affordable … pollution prevention is part of protecting families from costs they cannot afford,” said John Ray, senior director at YouGov, which conducted the poll, in a call with reporters on June 3.

Based in Washington, Peter Murchie worked at the EPA for 25 years before becoming the senior director of policy at the Environmental Protection Network, which commissioned the new poll. Murchie said both the Chemical Safety Board and EPA play important roles in preventing and responding to chemical disasters, including the deadly “white liquor” spill in Longview.

“EPA has a very important role both in the prevention of accidents like this one and of chemical exposure to workers and the community, and also the response, and you have seen in the reporting that the EPA is on scene with the emergency response folks,” Murchie told reporters on the press call.

The new poll shows that 82 percent of Trump’s notoriously loyal supporters say the president should be tougher on polluters, and 42 percent view Trump’s handling of the EPA less favorably than his overall job performance. Support for strengthening the EPA among all voters has risen from 50 percent in 2024 to 64 percent when the poll was conducted in late April, a few weeks before the deadly spill in Longview. Yet Trump and Zeldin are moving in the exact opposite direction in order to reduce costs and maximize profits for private industry.

“There’s this belief that the left wants more regulations and the right wants less,” Ray said. “But for most people, there is broad-based concern about making sure the government is doing whatever it is supposed to be doing to keep water clean and air clean and food clean and so on.”

Do You Know What’s in the Air Your Children Breathe?


Nearly half of kids in the US are breathing unhealthy air; it’s time for the EPA to return to its lifesaving mission of protecting their lungs.


An oil refinery, owned by Exxon Mobil, is the second largest in the country on 28th February 2020 in Baton Rouge, Louisiana, United States.
(Photo by Barry Lewis/InPictures via Getty Images)


Christy Sadreameli
Jun 05, 2026
Common Dreams


Parents have a lot on their minds. I am a mom of a 3-year-old and a 7-year old and a pediatric pulmonologist. Like many other parents, I am constantly juggling the logistics of family life, school, and work. Keeping my children healthy and safe is a priority.

Food is one example. I try to ensure my children eat healthy, nutritious food that won’t make them sick or contribute to the formation of chronic disease, like some ultra-processed foods can. As the parent of a picky eater, finding healthy foods my children will actually eat can be challenging.

I know that parents do not need another thing to be concerned about. They certainly shouldn’t have to worry about the air their children breathe. But the American Lung Association’s recent “State of the Air” report found that nearly half of kids in the US are breathing unhealthy air. More specifically, the report found that 33.5 million children, or 46% of people under 18 years old in the US, live in an area that received a failing grade for at least one measure of air pollution. More than 7 million children in the United States (10% of all kids) live in a community with failing grades for all three measures studied in the report.

This is unacceptable, especially because studies show that infants, children, and teens as a group are more susceptible to the health impacts of air pollution, and that some of these harms can be lifelong. Compared with adults, infants and children breathe more air relative to their body size and they are frequently playing outside where they are exposed to outdoor air. The fact that the lungs continue to develop throughout childhood plays a role.

Children should not have to pay the price with their health so that polluting industries can maximize their profits.

In the past year, there has been an increasing amount of attention paid to preventing chronic disease in children—for good reason. We all want to set our children up for the healthiest lives possible. But the conversation about chronic disease prevention must include cleaning up air pollution. Air pollution exposure in childhood can cause long-term harm by impeding lung growth, contributing to new asthma cases, causing flareups in people with asthma and other lung conditions, increasing risk of respiratory infections and more.

Air pollution can even harm children before they are born. Air pollution is linked to preterm birth, low birth weight, lower lung capacity, and other adverse birth outcomes. That means that exposure to air pollution during pregnancy and childhood could even set a child up for a lifetime of poor lung health. As children grow into adulthood, breathing air pollution can cause respiratory and cardiovascular harm, asthma attacks, lung cancer, heart attacks, stroke, even early death.

So what is driving the ground-level ozone pollution and particle pollution reported on in “State of the Air?” There are many sources, but the main ones include diesel- and gasoline-powered vehicles, power plants and other industrial sources, emissions from the oil and gas industry, and wildfires. Higher temperatures can exacerbate this, as heat accelerates the production of ozone. While the US has made incredible progress in cleaning up air pollution over the past 50 years, the changing climate is making air pollution more likely to form and more difficult to clean up.

Here is more bad news: While half of the children in the US are breathing unhealthy air, the US Environmental Protection Agency (EPA) is working to roll back and repeal safeguards designed to reduce air pollution. In recent months, EPA announced a rule to weaken limits to protect children from mercury and other toxic pollutants from power plants, eliminated the standards to regulate emissions from vehicles, and delayed implementation of a rule to reduce pollution from oil and gas wells. On top of that, EPA recently decided to eliminate health-related data from its analyses of clean air measures, meaning that the costs of pollution to our kids, families, and communities will not be counted as policies are rolled back.

This is particularly upsetting, as I see what an impact air pollution can have on children and families in my day-to-day work as a pediatric pulmonologist. For decades, EPA has calculated the costs of air pollution to the health and livelihood of people, including asthma attacks and premature deaths. EPA is still including the cost to industry in their economic analyses, which means it will be easier to achieve further rollbacks of regulations while omitting the devastating costs to children and communities. Children should not have to pay the price with their health so that polluting industries can maximize their profits.

The good news is that federal clean air protections work when they are enforced. The Clean Air Act is regarded as one of the most successful public health laws in US history. For 55 years, it has protected children, families, and communities from harmful pollution and driven innovation toward a cleaner, healthier future. The Clean Air Act gives EPA the authority and responsibility to assess and clean up air pollution from vehicles, power plants, and industries across the nation. We rely on EPA to protect our lungs. I urge EPA to return to its lifesaving mission of protecting human health by reducing deadly air pollution instead of allowing more of it, and value people’s lives and the health costs of pollution in their rulemaking processes.

As I read the labels on foods, buckle my sons into their car seats, and put their helmets on before they jump onto scooters and bikes, I also check the air quality on my phone. I teach my patients and their parents to do the same. But there is only so much I—or any parent—can do to protect my kids from air pollution.

EPA must protect our air and value our kids’ health. All lungs, especially little lungs, are counting on it.


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.


Christy Sadreameli
Dr. S. Christy Sadreameli is a pediatric pulmonologist at Johns Hopkins Hospital in Baltimore, Maryland, where she takes care of pediatric patients of all ages with a variety of pulmonary conditions. She is also a volunteer medical spokesperson for the American Lung Association to help communicate important health information to parents all over the country.
Full Bio >


TU Graz physicist presents mobile device for high-precision measurement of air pollutants



The UV dual-comb spectrometer detects harmful gases with unrivalled accuracy and sensitivity. The compact design allows mobile use for monitoring air quality with a range of several kilometers



Graz University of Technology

Optical configuration of the spectrometer 

image: 

The optical configuration of the UV dualcomb spectrometer.

view more 

Credit: Oliver WOlf - TU Graz





Birgitta Schultze-Bernhardt and her team at the Institute of Experimental Physics at Graz University of Technology (TU Graz) have developed a new type of UV dual-comb spectrometer that detects gaseous air pollutants with unrivalled accuracy and sensitivity. Using ultraviolet double laser light, the device measures the concentration of harmful gases such as formaldehyde within half a second. Thanks to its compact design and a measuring range of up to two and a half kilometres, the spectrometer is not only suitable for laboratory analyses, but also for mobile measurements in cities, industrial areas and agricultural regions.

Fingerprint of pollutants

As a starting point for its measurement, the device generates two laser pulses in the ultraviolet spectral range within fractions of a second. When this UV light hits gas molecules, it excites them electronically and causes them to rotate and vibrate – physicists refer to this as rovibronic transitions. These transitions are different for every gaseous substance and swallow up part of the laser light in a unique way. “Every air pollutant therefore has its own fingerprint, which our UV dual-comb spectrometer recognises,” says Birgitta Schultze-Bernhardt.

Schultze-Bernhardt and her team developed the first version of their spectrometer a good two years ago. At the time, it was the first of its kind in the world, but large laboratory set-ups were necessary for the measurements. The new version has been shrunk to the size of a cardboard removal box. One reason for this is that one laser source instead of two now generates the double laser pulse. “This also allows us to dispense with the complex electronic stabilisation of the system,” explains Birgitta Schultze-Bernhardt.

Resolution of 1 GHz

The new spectrometer can detect the frequencies of UV light with a resolution of 1 GHz and thus significantly outperforms all conventional UV spectrometers. This enabled the researchers to gain new, fundamental insights into the UV light absorption of the air pollutant formaldehyde: “We measured absorption patterns of formaldehyde that had never been observed experimentally before, as the resolution of any previous devices was too imprecise,” says Birgitta Schultze-Bernhardt.

57-year-old rotational constants corrected

The measurements in Graz have shown that the rotational constants of formaldehyde, which have been available in physics databases and textbooks since the 1960s, are incorrect. “In collaboration with the Harvard-Smithsonian Center for Astrophysics, Atomic and Molecular Physics in the USA, we have corrected the values of this fundamental, molecule-specific parameter by up to 15 per cent,” says Birgitta Schultze-Bernhardt. Collaboration with Rolf Breinbauer from the Institute of Organic Chemistry at TU Graz, who produced high-purity formaldehyde for the investigations in a two-stage process, also contributed to this progress in basic research.

Practical application in environmental protection

Beyond basic research, the spectrometer has the potential to make the measurement of air pollutants and gas leaks in cities and industrial areas much more precise and easier. “In principle, our device can accurately detect any semi-transparent, gaseous substance. And we are currently working on determining the concentration of several pollutants with a single measurement,” says Birgitta Schultze-Bernhardt. Funded by a Proof of Concept Grant from the European Research Council, the experimental physicist is also currently developing a UV spectrometer that can also be used by laypersons to monitor air quality, for example in companies or environmental authorities.

Funded by the Austrian Science Fund, ERC and NAWI Graz

The development of the UV dual-comb spectrometer is based on research projects led by Birgitta Schultz-Bernhardt, which were funded by the Austrian Science Fund FWF and the European Research Council. The NAWI Graz cooperation initiative financed the novel laser source of the current spectrometer as part of its infrastructure funding.

Thursday, June 04, 2026

 

15 centers selected for groundbreaking research network to transform heart transplant care



The American Heart Association is providing $4.5 million in funding to establish a new research network as the first part of a multi-phase initiative aimed at improving heart transplant outcomes




American Heart Association





DALLAS, June 3, 2026 — Nearly 60 years after the first successful heart transplant, the American Heart Association, a relentless force changing the future of health for everyone everywhere, is launching a bold new initiative to fundamentally transform how heart transplant care is delivered across the United States — addressing long-standing gaps in innovation, equity and patient outcomes. The Association’s first-ever heart transplant research network will include 14 medical research centers, along with a coordinating center that will bring together scientists from around the country to create a national, unified data, research and quality care infrastructure to improve heart transplant outcomes.

According to the American Heart Association’s 2026 Heart Disease and Stroke Statistics, about 4,500 heart transplantations were performed in the U.S. Even though that was the most performed in any year, more than 3,700 people remained on the waiting list for heart transplants in 2025.

“Despite decades of breakthrough advances in cardiovascular medicine, the system supporting heart transplantation has remained largely unchanged. Today, transplant recipients still face serious challenges, including difficulty detecting heart rejection early, reliance on immunosuppressive therapies that have seen little advancement over the past 20 years and inconsistent outcomes, especially among Black patients and children,” said Mariell Jessup, M.D., FAHA, the chief science and medical officer of the American Heart Association.

“This is one of the most high-stakes areas in medicine, yet innovation has lagged far behind. The American Heart Association has an urgent opportunity and responsibility to rethink care for heart transplant patients.”

Currently, heart transplant care is hindered by fragmented data systems, limited research investment and a lack of standardized quality improvement efforts. Many clinical guidelines are still based on expert consensus rather than robust, evolving evidence.

The new initiative aims to change that by fostering collaboration across institutions, generating actionable data and ensuring that advances reach all people equitably. The multi-phase initiative is designed to accelerate progress through coordination, data and discovery. The effort will focus on three key pillars:

Global Heart Transplant Data Infrastructure
In collaboration with leading transplant organizations, the Association will develop and manage a comprehensive heart transplant database. Unlike traditional registries, this dynamic, harmonized platform will enable real-time insights to support research, quality improvement and policy advancement.

Research Network for Breakthrough Science
The initiative will bring together top institutions across the country to form a research network focused on advancing care in critical areas, including:

  • Earlier and more precise detection of transplant rejection
  • Remote monitoring technologies to support patients outside the hospital
  • Viral surveillance to better manage infection-related risks
  • Development of safer, more effective therapies

The network will also support planning grants to accelerate clinical trials and advance research into immune tolerance and chronic rejection, two of the most pressing challenges in transplant medicine.

Coordinated Path Forward
Modeled after the Association’s Get With The Guidelines® success, a scalable quality improvement framework will be established to drive system-wide change by standardizing transplant care, advancing accessibility to transplants to all and improving long-term outcomes.

The initiative kicks off with the establishment of the new research network, with the four-year research grants starting July 1, 2026. The coordinating center will be led by a team under the direction of Emilia Bagiella, Ph.D., a professor of biostatistics in the Department of Population Health Science & Policy at the Icahn School of Medicine at Mount Sinai in New York City.

Other centers within the network include:

  • Baylor College of Medicine in Houston, Texas, led by Nandan Kumar Mondal, M.Sc., M.Phil., Ph.D., an assistant professor of surgery.
  • Cedars-Sinai Medical Center in Los Angeles, led by Andriana Nikolova, M.D., Ph.D., an assistant professor of cardiology.
  • Columbia University in New York City, led by Ersilia DeFilippis, M.D., FAHA, an assistant professor of cardiology.
  • Duke University School of Medicine in Durham, North Carolina, led by Adam DeVore, M.D., M.H.S., FAHA, an associate professor of medicine and medical director of the heart transplant program.
  • Icahn School of Medicine at Mount Sinai in New York City, led by Sean Pinney, M.D., a professor of medicine/cardiology and the Philip J. and Harriet L. Goodhart Chair of Cardiology.
  • Johns Hopkins University School of Medicine in Baltimore, led by Chetan Pasrija, M.D., an assistant professor of cardiac surgery and surgical director of heart failure and cardiac transplantation.
  • Mayo Clinic in Jacksonville, Florida, led by Jose Nativi-Nicolau, M.D., professor of medicine.
  • Medical University of South Carolina in Charleston, led by Ryan Tedford, M.D., FAHA, a professor of medicine/cardiology, the Dr. Peter C. Gazes Endowed Chair in Heart Failure and section head of heart failure and medical director of cardiac transplantation.
  • Stanford University in Stanford, California, led by Kiran Khush, M.D., professor of medicine.
  • University of California, San Diego, led by Paul Kim, M.D., an associate professor of medicine.
  • University of Colorado Denver in Aurora, led by Amrut Ambardekar, M.D., FAHA, a professor of medicine/cardiology and the director of the cardiac transplantation and cardiac amyloidosis programs.
  • University of Pennsylvania in Philadelphia, led by Maryjane Farr, M.D., FAHA, a professor medicine and the section chief of heart failure, transplant and mechanical circulatory support.
  • University of Utah in Salt Lake City, led by Josef Stehlik, M.D., M.P.H., the Christi T. Smith Professor of Medicine and medical director of the heart transplant program.
  • Vanderbilt University Medical Center in Nashville, led by Kelly Schlendorf, M.D., M.H.S., professor of medicine, director of heart failure and transplant, and medical director of the adult heart transplant program.

For patients and families navigating life after a heart transplant, this initiative represents hope for safer treatments, more personalized care and better long-term outcomes.

“By bringing together this exceptional data, research and clinical expertise, the Heart Association can help accelerate discoveries and translate them into better care for every patient, no matter who they are or where they live,” Jessup said. “With this ambitious effort, the American Heart Association is taking a critical step toward modernizing heart transplant care, ensuring that innovation in this field finally catches up with the rest of cardiovascular medicine.”

Funding scientific research and discovery through initiatives like this is a cornerstone of the century-old American Heart Association’s lifesaving mission. The Association has now funded more than $6.1 billion in cardiovascular, cerebrovascular and brain health research since 1949, making it the single largest non-profit, non-government supporter of heart and brain health research in the U.S. New knowledge resulting from this funding continues to save lives and directly impact millions of people in every corner of the U.S. and around the world.

More than 8 in 10 (82%) U.S. adults say they are confident in the American Heart Association to provide trustworthy information related to public health, according to a recent Annenberg Policy Center poll. The Association ranked second only to an individual’s personal health care provider.

###

About the American Heart Association 

The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day.  Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.

Why Mary, as the Immaculate Conception, became the patron saint of the US in the 1840s

(The Conversation) — Mary, as the Immaculate Conception, became patroness of the United States before the Vatican officially defined that belief as dogma.



Bridget Retzloff and Stephanie Shreffler
June 3, 2026 


(The Conversation) — Every year in March, tens of thousands of Americans take to the streets – and bars – to celebrate St. Patrick, the patron saint of Ireland. Similarly, Mexican Americans celebrate the Feast of Our Lady of Guadalupe, Mexico’s patron saint, in December.

But did you know that the U.S. has its own patron saint? Nearly 200 years ago, in May 1846, Catholic priests and bishops named the Virgin Mary patroness of the United States of America – specifically, under her title as the Immaculate Conception, referring to the belief she was conceived without sin.

According to the Catechism of the Catholic Church, which summarizes doctrine, a saint is a holy person who “leads a life in union with God through the grace of Christ and receives the reward of eternal life.” Catholics may venerate saints and ask them to intercede with God on their behalf. Some are recognized, whether formally or informally, as “patrons” of particular situations, conditions, identities or places, often inspired by their life on Earth.


We are librarians at the University of Dayton who work in the Marian Library and the U.S. Catholic Special Collection. We recently created a digital exhibit with objects pointing to the history of this devotion to Mary as the Immaculate Conception in the United States – objects that reflect both patriotism and faith.

The Immaculate Conception


‘The Immaculate Conception,’ by 16th-century painter Juan de Juanes.
Fundacion Banco Santander/Google Art Project via Wikimedia Commons

Mary is known by many names and titles, including the Virgin Mary, Mary of Nazareth, Our Lady of Lourdes, Holy Mother of God, Queen of Heaven, Seat of Wisdom and Mystical Rose.

One important title is Immaculate Conception, referring to the Catholic belief that Mary was free of “original sin” and therefore suitable to be the mother of Jesus Christ. The Catholic Church teaches that all other people are conceived with original sin as a result of Adam and Eve’s disobedience to God in the Garden of Eden.

Originally, the idea that Mary was free of original sin was widely debated within the Catholic Church. But the teaching was defined as dogma on Dec. 8, 1854, by Pope Pius IX. The feast day of the Immaculate Conception is now celebrated by Catholics on Dec. 8 each year. Even before its official acceptance, devotion to the Immaculate Conception influenced the art and teachings of the Catholic Church.


Patroness of the United States


How did Mary, as the Immaculate Conception, become patroness of the United States?

John Carroll, who became the first American bishop in 1790, was devoted to Mary throughout his life. In 1791, he and other American Catholic clergy consecrated the Diocese of Baltimore to Mary, asking her to “[preserve] from all evil” the people of the diocese.


Rembrandt Peale’s portrait of John Carroll, the first Catholic bishop from the United States.
Wikimedia Commons

Half a century later, in 1846, a council of priests and bishops from across the country officially named Mary, under her title as the Immaculate Conception, the patroness of the entire United States, asking her for “the aid of her prayers.”

Devotion to the Immaculate Conception has remained an important part of the faith lives of many American Catholics, even if they are unaware of her patronage of the United States. This devotion is demonstrated by the many churches that are named for the Immaculate Conception, jewelry depicting the Immaculate Conception and the inclusion of the Feast of the Immaculate Conception as a holy day of obligation in the U.S. – a day when Catholics are expected to attend Mass.

On Feb. 7, 1847, the Vatican approved the request to make Mary, as the Immaculate Conception, the patroness of the United States. This was seven years before the dogma was defined by the pope, pointing to the popularity of this devotion even before official recognition.


Bicentennial holy card


Many items in the Marian Library’s collection, such as holy cards, also demonstrate American Catholics’ devotion to Mary as the Immaculate Conception. A holy card is a small portable devotional tool, often including an image of Jesus or a saint on the front. Typically, a prayer, devotion, scripture passage or commemoration of an important event is printed on the reverse side.

One of our cards features an image of Mary as the Immaculate Conception above the words: “Immaculate Mary, Patroness of the United States, Pray for Us.” The reverse commemorates the bicentennial of the United States in 1976, followed by the motto of the United States, “In God We Trust.”

The image of Mary is a reproduction of “The Immaculate Conception of El Escorial,” a painting by 17th-century Spanish painter Bartolomé Esteban Murillo in the collection of Madrid’s Museo del Prado. The painting reflects artistic traditions that symbolize the theology behind the Immaculate Conception.



This holy card draws on symbols from the Book of Revelation.
The Marian Library, University of Dayton

Mary is shown with a blue garment: a color associated with faith, humility, the heavens and the sea. Since blue pigments were very expensive during the Renaissance, the color was reserved for important figures, particularly paintings of Mary.

Other symbols, though, are specific to Mary as the Immaculate Conception. She stands with a moon beneath her feet, inspired by the “apocalyptic woman” from the Bible’s Book of Revelation: “a woman clothed with the sun, with the moon under her feet, and on her head a crown of twelve stars.” Catholic theologians interpret this figure as a reference to Mary, establishing her as mother of all Christians.

In other artwork of the Immaculate Conception, Mary is depicted with a snake beneath her feet, a crown of 12 stars or a dragon – also inspired by Revelation, Chapter 12.


American rosary

Another important object of Catholic devotion, the rosary, encourages reflection on the lives of Jesus and Mary. The word can refer to a physical object – a set of 50 beads or knots on a string – or certain sets of prayers, including Hail Mary and Our Father. Touching the beads as they pray helps Catholics keep track as they recite the prayers.


This rosary mixes religious devotion with patriotic colors.
The Marian Library, University of Dayton

The “American Rosary” in our collection was designed by Marie George of New York in 1956, though archivists do not know exactly who she was. It uses beads in the patriotic colors of red, white and blue, and it includes a Miraculous Medal, which depicts Our Lady of the Immaculate Conception. A card included with the rosary encourages Catholics to offer prayers “for World Peace, with Justice and Charity.”
Across centuries

For much of U.S. history, Catholics in the United States often faced prejudice and discrimination. In the mid-19th century, when Mary as the Immaculate Conception was named patroness, the Protestant majority of the U.S. was deeply suspicious of Catholics’ loyalty to the pope.

The bicentennial holy card and the American rosary from the following century, both dedicated to the Immaculate Conception, reveal how American Catholics still sought to demonstrate that their faith and their patriotism did not conflict with each other.

In 2026 – the 250th anniversary of the United States, and the 180th anniversary of Mary’s patronage – some of that history may feel distant. The Catholic Church elected the first American-born pope, Leo XIV, in 2025, and the United States has seen a surge in Catholic conversions in 2026. But Catholics still ask Mary, as patroness of the U.S., for her intercession: not only in their lives, but for their country.



(Stephanie Shreffler, Religious Collections Librarian/Archivist and Associate Professor, University Libraries, University of Dayton. Bridget Retzloff, Assistant Professor and Coordinator of Art Collections and Exhibits, University of Dayton. The views expressed in this commentary do not necessarily reflect those of Religion News Service.)


The Conversation religion coverage receives support through the AP’s collaboration with The Conversation US, with funding from Lilly Endowment Inc. The Conversation is solely responsible for this content.

Tuesday, June 02, 2026

 

Dali Civil Trial Delayed to Consider Legal Issue After Most Claims Settle

Dali and wreckage of Francis Scott Key Bridge
The civil trial related to the Dali was delayed indefinitely after most of the claims have been settled (Army Corps of Engineers photo)

Published Jun 1, 2026 3:07 PM by The Maritime Executive


The U.S. federal district court judge scheduled to hear opening arguments in the civil trial related to the containership Dali expressed frustration while agreeing to instead postpone the trial indefinitely. Most of the claims have now been settled, and all the remaining parties agreed to the delay, in part to consider a legal issue related to the remaining claims.

The owners of the Dali, Grace Ocean, and the manager of the vessel, Synergy Marine, made a last-minute motion on Saturday, May 30, to stay the civil proceedings, and Judge James Bredar ruled on Monday, June 1, to delay the trial instead of proceeding to opening arguments. He said that while it is typical to have last-minute settlements in civil trials, he still expressed general frustration for the court and the public after more than two years of legal process on the case that sought to test the ability of the companies to limit their civil liabilities.

The companies argued that all but 11 of the 54 initial claims filed in the civil case have been settled or voluntarily dismissed. They noted that all the wrongful death claims were settled, as well as the claims from the injured survivors. The court had denied a previous motion for a delay, saying it was time for the families to have their day in court. In addition, all but one cargo claim and one property damage claim (from the City of Baltimore) have been resolved.

Lawyers for the City and County of Baltimore agreed for different reasons that the trial should be delayed. They said a potential criminal conviction would change the remaining case as it would “conclusively demonstrate that petitioners (Grace Ocean and Synergy) cannot invoke the protection of the Limitation of Liability Act.” 

Baltimore is claiming property damage for a water main that ran alongside the bridge and under the river that was damaged by the collapse. The remaining claims are economic loss claims.

At issue is a 1927 U.S. Supreme Court decision that bars economic loss recoveries caused by negligence unless there were also physical damages to properties. Most of the remaining claims cite economic losses due to the closure of the port and the loss of the bridge. The judge has given all the parties two weeks to file new motions on this issue. Judge Bredar expects the issue to be fully briefed by mid-July.

The largest of the settlements was a record $2.25 billion with the State of Maryland, as well as $100 million with the federal government. Terms of the settlements with the families have not been announced. Others, including the employer of the road crew working on the bridge, and cargo claims, such as one from Zim and MSC, have also been settled.

Synergy Marine and one of its port superintendents, however, were indicted by the federal government for issues related to the operation of the Dali. They are also facing charges of providing false information to the investigators, including the National Transportation Safety Board. 

 

U.S. overdose deaths dropped in 2024 amid uneven progress, study finds



Researchers found racial/ethnic gaps persist and overdose deaths involving only stimulants continued to rise, despite national declines overall



University of California - San Diego




Researchers from the University of California San Diego have found that U.S. overdose death rates declined dramatically between 2023 and 2024, marking the first recorded drop in all four waves of the nation’s overdose crisis. The study, published on June 2, 2026 in the journal Addiction, found that the nationwide decrease was largely driven by falling deaths involving illicit fentanyl, both alone and in combination with stimulants such as methamphetamine and cocaine. Despite the encouraging trend, researchers warn that overdose deaths involving stimulants without fentanyl, as well as xylazine-related deaths, continue to rise and racial disparities remain severe.

“We are seeing a historic shift in the overdose crisis,” said Joseph Friedman, MD, PhD, MPH, resident physician in the Department of Psychiatry at UC San Diego School of Medicine and the study’s first author. “But this is not the end. The substances involved are changing, some parts of the crisis are still growing, presenting new challenges. We need to avoid interpreting declining national numbers as a sign that the crisis has been solved.”

The researchers analyzed national overdose mortality data from the Centers for Disease Control and Prevention’s Wide-ranging ONline Data for Epidemiologic Research (WONDER) database, examining every recorded overdose death in the United States between 1999 and 2024. The team tracked trends by substance involvement and race and ethnicity, allowing them to map how the overdose crisis has evolved over time.

The study found that the national overdose death rate fell by 24.4% between 2023 and 2024, dropping to 23.7 deaths per 100,000 people. The decline was primarily linked to decreases in fentanyl-related deaths. Deaths involving fentanyl without stimulants fell from 31,193 in 2023 to 19,673 in 2024, while deaths involving fentanyl combined with stimulants dropped from 41,583 to 28,062.

Researchers describe the U.S. overdose epidemic as unfolding in four waves: prescription opioids, heroin, fentanyl and, most recently, fentanyl combined with stimulants such as methamphetamine or cocaine. The new findings show that the fourth wave — considered especially lethal because of use of multiple substances — declined for the first time in 2024.

At the same time, the study identified emerging warning signs. Deaths involving stimulants without fentanyl continued increasing, rising from 18,142 deaths in 2023 to 18,907 in 2024. These deaths accounted for 17.3% of overdose fatalities in 2023 but grew to 23.8% in 2024. Xylazine, a veterinary sedative increasingly found in the illicit drug supply, was also implicated in a growing share of fentanyl-related overdose deaths.

Researchers warn that if these trends continue, stimulants such as methamphetamine and cocaine may soon surpass opioids as the defining addiction-related public health challenge in the U.S.

“Overdose deaths are only one part of the picture,” said Steffanie Strathdee, PhD, senior author of the study and professor of medicine at UC San Diego School of Medicine. “Stimulants are also associated with long-term cardiovascular, neurological and psychiatric harms that can devastate individuals and communities.”

The researchers also found substantial racial and ethnic disparities. Non-Hispanic Black individuals experienced the largest decline in overdose death rates between 2023 and 2024, with rates falling by 29.3%. However, the overdose death rate for Black Americans remained more than 1.5 times higher than the national average in 2024. Meanwhile, Non-Hispanic American Indian and Alaska Native populations had the highest overdose death rate of any group studied, at 50.8 deaths per 100,000 people — more than double the national average.

The study also showed that cocaine-related deaths disproportionately affected Black Americans, while methamphetamine-related deaths disproportionately affected American Indian and Alaska Native communities. Xylazine-related overdose deaths were also especially elevated among Black Americans.

Researchers say the causes of the recent decline in overdose deaths are likely complex and multifactorial. Possible explanations include a reduced number of susceptible individuals, greater awareness of fentanyl risks, expanded availability of naloxone, changes in drug use behavior and possible disruptions in the illicit fentanyl supply chain. The authors caution that provisional 2024 mortality data could still change slightly as final records become available.

Even with the recent decline, overdose deaths in the United States remain extraordinarily high compared with other countries. Even with the recent decline, overdose deaths in the United States remain a global outlier. Researchers note that approximately 80,000 people died from drug overdoses in the U.S. in 2024 — far more than would be expected if the country had overdose death rates comparable to Western Europe. Researchers say continued investment in addiction treatment, harm reduction programs and targeted public health interventions will be essential to sustaining progress and reducing persistent inequities.

“National trends can improve while vulnerable communities continue to suffer disproportionately,” Friedman said. “The next phase of the response needs to focus not only on lowering overall deaths, but on making sure those gains reach the populations that have been hit hardest.”

Read the full study: Charting the Decline of the Fourth Wave: US Overdose Deaths by Race, Ethnicity and Substance Involvement

Additional co-authors on the study include: Annick Borquez, PhD, and Tommi L. Gaines, DrPH, from UC San Diego; Joseph J. Palamar, PhD, from NYU Grossman School of Medicine; Daniel Ciccarone, MD, from UC San Francisco; Chelsea L. Shover, PhD, from UCLA. 

The study was funded, in part, by the National Institute of Drug Abuse (1U01DA063078-01, R01DA054190, R01DA057630, K01DA05771, R33DA061260, DP2DA049295). 

Palamar reported receiving personal fees from the Washington-Baltimore High Intensity Drug Trafficking Areas program, Elsevier, Wiley, Rutgers University, Arizona State University, the University of Southern California, the Substance Abuse and Mental Health Services Administration, Queensland University, the National Network of Public Health Institutes, Alta Mira Recovery programs and Dartmouth University, and nonfinancial support from NIH/NIDA, the University of Florida, Rx Summit, the American College of Neuropsychopharmacology and the Reagan-Udall Foundation for the FDA during the conduct of the study. Ciccarone reports personal fees from Emergent Biosciences outside the submitted work. All other authors declare no conflict of interest.

MINDFULNESS

Five minutes of prayer reduces pain and anxiety in primary care patients, randomized trial finds



New UMSOM study suggests in-person intercessory prayer is a safe, low-cost complement to standard medical treatment




University of Maryland School of Medicine





A randomized controlled trial conducted at the University of Maryland School of Medicine has found that a five-minute session of proximal intercessory prayer (PIP) — in-person prayer offered by a trained volunteer — significantly reduced pain and anxiety in primary care patients compared to a music control group. The findings, published in the May/June 2026 issue of Annals of Family Medicine, suggest that proximal intercessory prayer may offer a practical, non-pharmacologic complement to conventional care, particularly for underserved populations.

Researchers enrolled 180 patients from a university family medicine practice who reported clinically significant pain (having a score ≥4 on a 0–10 scale) or anxiety (as measured on the GAD-7 scale). After their medical appointments, participants were randomly assigned to receive either five minutes of Christian intercessory prayer from a trained volunteer — incorporating laying-on-of-hands — or five minutes of soft music as a control. Participants were followed up at two and six weeks.

Key Findings

  • Pain: Prayer group participants reported significantly greater pain reductions immediately after the session and at the two-week follow-up compared to the music group. The difference was not statistically significant at six weeks.
  • Anxiety: Prayer group participants showed significantly greater reductions in anxiety scores immediately after their treatment. This effect persisted at two and six weeks suggesting durable effects lasting at least a month and a half.
  • Safety and acceptance: No participants reported adverse events. Ninety-seven percent of prayer recipients were neutral, agreeable, or strongly agreeable to having PIP available as part of future medical visits.
  • Who benefited most: Black participants reported larger reductions in both pain and anxiety following prayer — a finding the authors consider particularly meaningful given documented inequities in pain treatment and the high rates of prayer use as complementary medicine among Black Americans.

Why It Matters

Prayer is the most common form of complementary medicine in the United States, used by 43% of Americans with 62% of this group identifying as Christian. Despite this widespread use, rigorous clinical trials of in-person intercessory prayer have been scarce. This study is among the first well-powered randomized controlled trials of proximal intercessory prayer conducted in a standard primary care setting.

"Proximal intercessory prayer was safe, effective, and well-received as complementary treatment for pain and anxiety," said lead author Katherine Jacobson, MD, Assistant Professor of Family and Community Medicine at the University of Maryland School of Medicine. "It may be a low-cost, non-pharmacologic, effective adjunct to standard care with particular relevance for underserved populations."

“The prayer intervention was effective regardless of the patient’s faith or no faith,” said co-author Joshua W. Brown, PhD, Professor of Psychological and Brain Sciences at Indiana University and Director and Co-founder of the Global Medical Research Institute. “Our findings add to research showing how prayer changes brain function in ways that promotes health.”

Dr. Brown is the author of the newly released book Proving a Miracle (Harper, 2026). He was diagnosed with a brain tumor over 20 years ago while just starting his career as a neuroscientist. That sparked his interest in whether prayer has medical benefits and led to numerous medical studies of healing prayer around the world, as he describes in his new book.

Context and Limitations

The study population was predominantly Black, female, and low-income — reflective of the clinic's patient base but limiting broader generalizability. Because blinding participants or prayer practitioners is not possible without undermining the ecological validity of the intervention, placebo effects and non-specific factors such as human presence and touch cannot be fully ruled out. The authors note that future studies should include a control condition with interpersonal contact and touch but without prayer, to better isolate PIP's specific effects.

About the Study

The trial was registered on ClinicalTrials.gov (NCT07565142) and approved by the University of Maryland Baltimore Institutional Review Board. Funding was provided by a Global Medical Research Institute MESH Grant. The study was conducted by researchers from the University of Maryland School of Medicine, Indiana University, and the Global Medical Research Institute.